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Hepatic alterations are 
accompanied by changes to 
bile acid transporter-expressing 
neurons in the hypothalamus after 
traumatic brain injury
Damir Nizamutdinov1,2, Sharon DeMorrow3,4, Matthew McMillin3,4, Jessica Kain1, 
Sanjib Mukherjee1, Suzanne Zeitouni1, Gabriel Frampton3,4, Paul Clint S. Bricker1, 
Jacob Hurst1 & Lee A. Shapiro1,2
Annually, there are over 2 million incidents of traumatic brain injury (TBI) and treatment options are 
non-existent. While many TBI studies have focused on the brain, peripheral contributions involving 
the digestive and immune systems are emerging as factors involved in the various symptomology 
associated with TBI. We hypothesized that TBI would alter hepatic function, including bile acid system 
machinery in the liver and brain. The results show activation of the hepatic acute phase response by 
2 hours after TBI, hepatic inflammation by 6 hours after TBI and a decrease in hepatic transcription 
factors, Gli 1, Gli 2, Gli 3 at 2 and 24 hrs after TBI. Bile acid receptors and transporters were decreased 
as early as 2 hrs after TBI until at least 24 hrs after TBI. Quantification of bile acid transporter, ASBT-
expressing neurons in the hypothalamus, revealed a significant decrease following TBI. These results are 
the first to show such changes following a TBI, and are compatible with previous studies of the bile acid 
system in stroke models. The data support the emerging idea of a systemic influence to neurological 
disorders and point to the need for future studies to better define specific mechanisms of action.
Traumatic brain injury (TBI) represents a serious socioeconomic concern. There are over 2 million reported cases 
of TBI each year and treatment options are lacking. Due to the nature of its direct impact in the brain, diagnosis 
and treatment of TBI has been targeted towards neurological mechanisms. There is an extensive literature regard-
ing the numerous anatomical and molecular changes that are observed in the central nervous system (CNS) fol-
lowing head trauma. However, there is also evidence that systemic mechanisms engaged after TBI may negatively 
impact neurological function1.
Neuroinflammation, believed to be a key player in the neuropathological response to TBI, may also influence 
systemic alterations2–6. Following a TBI, a number of chemokines and cytokines are released in the brain as part of 
the neuroinflammatory response7,8. Interestingly, neuroinflammatory responses have previously been associated 
with significant changes to the expression of almost a thousand genes in the liver9. Moreover, some of the cytokines 
typically seen elevated in the brain across a wide range of TBIs include, tumor necrosis factor-α (TNF-α ), 
interleukin-1β (IL-1β ), interleukin-6 (IL-6), and interferon (IFN)10–13. Three of these aforementioned cytokines 
(TNF-α , IL-1β . IL-6) are known as acute phase response effector proteins. Previous studies have demonstrated 
that these acute phase effector proteins are elevated in the brain and in serum after TBI, and that elevated serum 
levels result in binding to hepatocytes, thus stimulating the hepatic acute-phase response (APR)9,14.
The APR is a major component of the systemic response to tissue damage, infection, inflammation and 
trauma, including neurotrauma15,16. The APR is coordinated primarily by the liver17 via the release of regulatory 
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acute-phase proteins9. The positive acute-phase proteins include, C-reactive protein (CRP), haptoglobin, serum 
amyloid A (SAA), and serum amyloid P (SAP)18–20. Once released, these proteins modulate the inflammatory 
response, stimulate the complement system, scavenge free radicals and neutralize enzymatic activity16. The col-
lective action of initiation of the APR is intended to minimize tissue damage and initiate repair21–23. Considering 
that we and others have demonstrated elevated levels in the brain of the acute phase effector proteins, TNF-α , 
IL-1β and IL-6 after a TBI7,24, and the fact that elevated CNS cytokines are rapidly followed by elevated levels in 
the systemic circulation21–23, we hypothesized that there would be elevated acute phase response proteins in the 
liver, indicative of a hepatic APR after TBI.
To further assess hepatic alterations after TBI, we examined hedgehog signaling. Increased hedgehog signa-
ling in the liver has been found during many types of liver injury25. Hedgehog signaling is comprised of several 
hedgehog molecules including Sonic hedgehog (Shh) and Indian hedgehog (Ihh). Hedgehog signaling results in 
the nuclear localization of the Gli family (Gli 1, Gli 2, Gli 3) of transcription factors26–28. The cumulative effect of 
activating hedgehog pathways includes the accumulation, mobilization and activation of inflammatory cells25, 
including B29 and T cells30, as well as regulating the expression of Gli target genes31. Thus, this study assessed gene 
expression of hedgehog and Gli in the liver, in order to provide insight into whether or not TBI alters hepatic 
functioning. Hepatic inflammation was also assessed at the level of transcription and translation.
The bile acid system may represent another hepatic system that is altered following a TBI32. In humans and 
mice, bile acids are predominantly synthesized in the liver and stored in the gall bladder (rats lack a gall bladder, 
but have an intestinal modification to serve similar functions). The molecular machinery for bile acid synthesis 
and metabolism are present in the CNS, as are some of the bile acid transporters and receptors33–36. Bile acid 
transporters are central to maintaining bile acid circulation and homeostasis37, and specific transporters carefully 
regulate entry and removal from the CNS. Blood brain barrier (BBB) breakdown can facilitate bile acid entry into 
the brain38. Once in the brain, bile acids can be beneficial39 or detrimental32,38 depending on the physiological 
conditions, as well as the type and location of the receptors to which they bind40. Bile acids receptors may be 
cell-surface or nuclear, and have tissue-specific effects related to cholesterol synthesis, bile acid synthesis, and 
other g-protein mediated effects41,42.
Alterations to the hepatic and/or brain bile acid systems have been shown to influence neurological func-
tion in several different animal models. For example, in an acute liver failure model, bile acid signaling was 
shown to be involved in neurological decline32,43,44. Other studies using stroke models have demonstrated that 
the bile acid, tauroursodeoxycholic acid, reduces apoptosis and is neuroprotective after stroke45,46. Moreover, 
McMillin M et al.40, have shown in a model of cholestasis, that bile acid signaling was capable of suppressing the 
hypothalamic-pituitary axis (HPA). It is pertinent to note that the HPA is known to be dysfunctional following 
TBI47,48.
Considering the importance of the bile acid receptors and transporters in mediating bile acid signaling, as 
well as the fact that previous studies illustrate direct bile-acid mediated neurological effects, the current study was 
designed to test the hypothesis that TBI results in alterations to the bile acid receptors and transporters in the liver 
and hypothalamus. Our working model for this hypothesis is shown in Fig. 1. Briefly, we pose that the increase in 
IL-1β , IL-6 and TNF-α after TBI results in activation of the hepatic APR. The APR precedes hepatic inflammation 
and altered bile acid release. Because a TBI results in blood brain barrier breakdown, bile acids enter the brain in 
concentrations outside of the typical regulation by the bile acid transporters. Thus, dysregulation of brain bile acid 
homeostasis after TBI may contribute to detrimental neurological outcomes.
Results
Lateral fluid percussion injury (FPI) selectively elevates hepatic acute phase proteins. Because 
we have previously demonstrated elevation in the brain of acute phase effector proteins7, we assessed whether 
there would also be an acute phase response in the liver. Therefore, we assayed acute phase proteins in the liver 
at 2 and 6 hrs after FPI. The results showed that CRP is significantly elevated in the liver at 2 hrs following TBI 
(F(1,14) = 5.56, P < 0.04), but not at 6 hrs after TBI (Fig. 2a). Analysis of haptoglobin showed a trend toward sig-
nificant elevation in the liver at 6 hrs after TBI (F(1,14) = 4.033, P = 0.061, NS), however there were no significant 
differences at 2 hrs after TBI (Fig. 2b). Analysis of serum amyloid protein revealed no significant differences at 
either of the examined time points (Fig. 2c).
Hepatic inflammation after FPI. Because the APR is associated with hepatic inflammation, we next exam-
ined inflammatory cytokines and chemokines in the liver by polymerase chain reaction (PCR). We hypothesized 
that the message for inflammatory protein translation in the liver would be initiated very early after TBI, because 
it rapidly follows the APR. The results from the analysis of a cytokine/chemokine PCR array are shown in Fig. 3. 
Numerous significant changes were detected using the inflammatory panel at 6 hrs after TBI (Fig. 3a). In order 
to determine if the increased ribonucleic acid (RNA) was subsequently accompanied by increased expression 
of inflammatory proteins, we performed a multiplex analysis of several cytokines in the liver in different time 
points after TBI. The results revealed significant elevation of chemokine (CC motif) ligand 2 (CCL2) in the liver 
beginning at 1 day after FPI (t(5) = 4.864; P < 0.05), reaching a maximum level at 3 days after FPI (t(5) = 10.040; 
P < 0.0001). No significant difference was observed at 6 hours or 7 days after FPI (Fig. 3b). We also found no 
significant differences in custom cytokine panel consisting of CCL2, chemokine (CC motif) ligand 5 (CCL5), 
chemokine (C-X-C motif) ligand 1 (CXCL1), or interleukin-4 (IL-4), although a trend toward increased CCL5 
and IL-4 were observed at 6 hrs after FPI, compared to shams (Not shown).
Hedgehog and Gli alterations in the liver after FPI. Because hedgehog signaling is associated with 
accumulation and mobilization of immune cells in the liver, and because Gli expression is an indicator of hedge-
hog activation, we examined levels of messenger ribonucleic acid (mRNA) expression of hedgehog homologues 
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and their effectors, the Gli family proteins, in the liver at 2, 6, and 24 hrs after FPI. Ihh mRNA levels significantly 
decreased (vs. sham, P < 0.05) at 2 hrs after TBI, but not at 6 or 24 hrs post-TBI (Fig. 4a). Shh expression levels 
were significantly decreased at 2 and 24 hrs after (vs. sham, P < 0.05), but not at 6 hrs (Fig. 4b). Gli 1, Gli 2 and 
Gli 3 were all significantly decreased at 2 and 24 hrs time points after FPI (Fig. 4c–e). Gli 2 was also significantly 
decreased at 6 hrs after FPI, whereas no significant differences were found at this time point for Gli 1 and Gli 3 
(Fig. 4c–e).
Figure 1. Proposed mechanisms of hepatic influences to TBI. An injury to the brain stimulates a hepatic 
response via (A) cholinergic inputs and (B) via increased serum concentrations of the acute phase effector 
proteins, IL-1β, IL-6 and TNF-α . Serum elevations of these proteins bind to hepatocytes in the liver and 
stimulate production in acute phase proteins. This increased production of acute phase proteins is associated 
with altered liver cell function, including changes in protein synthesis, proliferation and metabolic function. 
As part of the acute phase response, leukocytosis occurs that is associated with an increase in the production 
of inflammatory cytokines and chemokines by the liver. Functionally, the collective alterations to liver cell 
function and hepatic inflammation result in changes to the bile acid milieu, bile acid receptors and bile acid 
trasnsporters. We hypothesize that because of blood-brain-barrier breakdown, any one or more of these hepatic 
mechanisms can influence neuronal dysfunction following TBI.
Figure 2. Multiplex assay of acute phase response protein levels in the liver. In (a) C Response Protein 
(CRP) is significantly elevated in the liver at 2 hrs following FPI (P < 0.04) FPI, but not at 6 hrs after FPI in mice. 
In (b), analysis of haptoglobin levels in the liver after FPI revealed no significant difference at 2 hrs after FPI, 
and a trend towards significance (P = 0.061) at 6 hrs after FPI. In (c), analysis of serum amyloid P component 
(SAP) revealed no significant differences at 2 or 4 hrs after FPI. Taken together, these results demonstrate 
differential elevations of acute phase proteins in the liver following an FPI. Such data highlights the importance 
of examining multiple acute phase proteins, at several time points in order to detect activation of the APR. Data 
are presented as means ± the standard error of the mean (SEM). Experiments were performed in triplicate at 
minimum, and a value of P = < 0.05 was considered statistically significant.
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Hepatic bile acid system changes after FPI. Considering that alterations to hepatic function have been 
associated with changes to the bile acid system, we next examined bile acid receptors and transporters in the liver 
following FPI. The results showed that G-protein coupled bile acid receptor-1 (TGR5) was significantly decreased 
at 2 and 24 hrs after TBI and a trend towards reduced TGR5 was observed at 6 hrs after TBI (Fig. 5a). Alternatively, 
no significant differences were observed for apical sodium dependent bile acid transporter (ASBT) or sodium/
bile acid cotransporter (NTCP) at any of the time points examined (Fig. 5b,c). Expression level of solute carrier 
organic anion transporter family member 1A4 (OATP) was significantly increased (vs. sham, P < 0.05) at 24 hrs 
time point after TBI, without significant changes at 2 and 6 hrs (Fig. 5d).
Brain bile acid system changes after FPI. Recent evidence also demonstrates the presence of bile acid 
machinery in the CNS40,49. We performed immunohistochemistry for the bile acid transporter ASBT and found 
that ASBT-expressing neurons were predominately located in the hypothalamus (Fig. 6a,b), with a smaller 
number of ASBT-expressing neurons located in the raphe nucleus. We performed quantitative analysis of the 
ASBT-expressing neurons on day 7 in the hypothalamus of sham (Fig. 6a) and after TBI (Fig. 6b). We observed 
ASBT+ neurons in the medial and lateral preoptic area, the dorsal medial nucleus of the hypothalamus and 
the lateral hypothalamus. Although none of these regions showed significant changes when analyzed separately 
(not shown), when we pooled the three regions, we observed a significant loss of ASBT-expressing neurons fol-
lowing TBI (t(9) = 6.64, P < 0.05), compared to shams (Fig. 6c). We also observed ASBT-expressing neurons in 
zone incerta, subparafacicular thalamic nucleus and periaqueductal gray area. We did not detect any significant 
changes in these regions after TBI (not shown).
Discussion
The results from this study demonstrate several hepatic, inflammatory, and bile acid system changes, includ-
ing changes in the brain bile acid machinery, following FPI. These changes include elevation of hepatic acute 
Figure 3. Hepatic inflammation after FPI. In (a), results from an inflammatory PCR array panel run from 
liver homogenates at 6 hrs after FPI is shown. Numbers in red font color depict significantly different (P < 0.05) 
from sham. In (b), Inflammatory protein levels of CCL2 are shown at 6 hrs, and 1, 3 and 7 days after FPI. The 
results show that CCL2 in the liver is significantly increased at 1 (P < 0.05) and at 3 (P < 0.003) days after TBI, 
but not at 6 hrs or 7 days after FPI. CCL2 is commonly used as a general indicator of inflammation and the 
peak increase at 3 days post-FPI mirrors our previous result in the brain25. Data are presented as means ± SEM. 
Experiments were performed in triplicate at minimum, and a value of P = < 0.05 was considered statistically 
significant. *< 0.05; **< 0.005.
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phase proteins, hepatic inflammation, alterations to bile acid receptors and transporters in the liver, and a loss 
of ASBT+ neurons in the hypothalamus. Previous studies using various brain injury models have demonstrated 
some aspects of hepatic alterations50–52. However, this study is unique in that it is more comprehensive, and is the 
first to demonstrate alterations to the bile acid system in the liver and brain following TBI.
The APR is typically initiated in response to most inflammatory triggers in order to coordinate the innate 
immune response53–55. A major role for the liver in initiating the APR and mediating the inflammatory response 
has been well-described17–20. Triggers for the APR include elevations of the cytokines IL-1β, IL-6 and TNF-α , 
which can bind directly to hepatocytes and induce the synthesis and subsequent release of acute phase response 
proteins. Previous studies are inconsistent in regards to TBI activating the APR; where some studies support TBI 
activation of the APR20,52,56,57, and others do not58. It is possible that some of these discrepancies can be explained 
by differential sensitivity of the markers, lack of temporal specificity, not examining enough of the proteins, or 
that not all brain injuries induce the APR. Nevertheless, the current study provides additional evidence for acti-
vation of the APR after TBI, as well as data that are consistent with previous reports of hepatic inflammation 
following various types of brain injury50–52.
In addition to modulating the APR, the liver also controls the production of bile acids. Bile acids have been 
reported throughout the brain32,40 and bile acid receptor and transporter expression in the brain has also been 
established32,39,42,59–61. The fact that bile acid receptors and transporters are found throughout the brain suggests 
the possibility that bile acids might be able to modulate neuronal function38. Of particular interest to the current 
study, bile acid receptors and transporters are found in the hypothalamus and hypothalamic function seems to be 
particularly sensitive to bile acid modulation36,40,62. Support for a role of bile acid receptor activation on neurolog-
ical function was demonstrated by data showing that the bile acid chenodeoxycholate (CDCA) is a potent antag-
onist of N-Methyl-D-aspartic acid (NMDA) and gamma-aminobutyric acid63. CDCA significantly decreased the 
firing rate of hypothalamic neurons and synchronized network activity63.
Within the hypothalamus, we found ASBT+ neurons in medial and lateral portions of the preoptic area, the 
dorsal medial nucleus and the lateral hypothalamus. The dorsal medial nucleus is involved in regulating circadian 
rhythm, feeding, and drinking behavior, as well as body metabolism64,65. Considering that sleep cycles are often 
altered following TBI, it is possible that dysregulation of the bile acid system in this nuclei is involved in this alter-
ation. Interestingly, the lateral portions of the preoptic nuclei, and the lateral hypothalamus, have also been shown 
to be involved in sleep onset66,67. Considering that we observed ASBT+ neurons in these hypothalamic nuclei, it 
is possible that bile acid system changes after TBI might be involved in sleep and/or circadian deficits after TBI.
Further evidence supporting a mediating role of the bile acid system on neurological function is obtained from 
studies showing that the bile acids tauroursodeoxycholic acid (TUDCA) and ursodeoxycholic acid (UDCA) are 
neuroprotective in protein misfolding disease models, including Parkinson’s, Huntington’s and Alzheimer’s dis-
eases49. It is also now clear that bile acids function as nutrient hormones that can activate specific nuclear recep-
tors, G-protein coupled receptors68, and cell signaling pathways in a physiological relevant manner69. Therefore, 
Figure 4. Expression levels of hedgehog and Gli proteins in the liver at 2, 6 and 24 hours after FPI in mice. 
In In (a), Indian hedgehog (Ihh) is significantly decreased at 2 hrs after FPI in mice, but not at 6 or 24 hrs post-
FPI. In (b), sonic hedgehog (Shh) expression is decreased at 2 and 24 hrs after TBI, but not at 6 hrs. In (c–e), Gli 
1, 2 and 3 are all significantly decreased at 2 and 24 hrs after FPI. Gli 2 is also significantly decreased at 6 hrs after 
FPI, whereas no differences are found at this time point for Gli 1 and Gli 3. Data are presented as means ± SEM. 
Experiments were performed in triplicate at minimum, and a value of P = < 0.05 was considered statistically 
significant. *< 0.05.
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the bile acid system can mediate neurological function through multiple mechanisms, and the homeostasis of this 
system is altered following TBI.
The finding of decreased hedgehog and Gli mRNA in the liver early after FPI is somewhat surprising, and as 
mentioned in the methods, may be underestimated. A decrease in these signaling molecules in the liver results in 
Figure 5. Bile acid receptor and transporter expression in the liver at 2, 6 and 24 hours after FPI. In (a), 
TGR5 is significantly decreased at all three time points after FPI. In (b,c), no changes are seen for NTCP or 
ASBT. In (d), OATP is significantly elevated at 24 hrs after FPI, but not at 2 or 6 hrs after FPI. Taken together, the 
data show altered bile acid system in the liver after FPI. Data are presented as means ± SEM. Experiments were 
performed in triplicate at minimum, and a value of P = < 0.05 was considered statistically significant. *P < 0.05.
Figure 6. ASBT immunohistochemistry in the hypothalamus at 7 days after FPI in mice. We developed 
a custom antibody that allows for the identification of neuronal expressed ASBT in the brain. In (a), ASBT 
staining in the dorsal medial nucleus of the hypothalamus of a sham mouse is shown 7 days after sham FPI. In 
(b), a significant decrease in ASBT-labeled cells is observed in the dorsal medial nucleus of the hypothalamus 
at 7 days FPI. In (c), stereological analysis of ASBT+ cells in the hypothalamus of sham and FPI (mild/
moderate) mice shows a significant (P < 0.05) decrease at 7 days after FPI. These results support the hypothesis 
that TBI induces alterations to the bile acid system in the liver (Fig. 5) and in the brain. Data are presented as 
means ± SEM. P = < 0.05 was considered statistically significant. Scale bars in A and B = 50 μ m.
www.nature.com/scientificreports/
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a decrease in proliferation of hepatocytes. Alternatively, an increase in hedgehog and Gli signaling is associated 
with inflammation and hepatic repair. What is interesting is the apparent cyclical pattern of the results, suggesting 
a possible biphasic response in the liver at early time points after TBI. Previous in vitro and in vivo studies exam-
ining acute liver injury have demonstrated a biphasic hepatocyte response that may correspond to hepatocyte 
apoptosis and/or liver necrosis70,71. Thus, it is possible that at later, or different time points than we examined, 
hedgehog and Gli signaling are increased, as the liver mobilizes immune cells and attempts to restore homeostatic 
function72. Future studies are needed to clarify this disparity.
In conclusion, this study provides ample and novel evidence supporting TBI-induced alterations to the liver 
and to the bile acid system, through several systems. Considering the findings that the bile acid system can be 
manipulated to alter neuronal function, it is possible that targeting the bile acid system could be useful in treating 
TBI. Future studies are needed to explore the potential interactions between the liver and brain, and to determine 
if manipulating liver/brain interactions after TBI will improve outcomes.
Methods
Fluid percussion traumatic brain injury. Procedures on research animals were conducted with approval 
of the Baylor Scott & White Animal Care and Use Committee in accordance with the recommendations of the 
Guide for the Care and Use of Laboratory Animals (Eighth edition) revised by the National Research Council in 
2011 (published by the National Academies Press), National Institutes of Health and American Association for 
the Accreditation of Laboratory Animal Care (AAALAC) guidelines and the Public Health Service (PHS) Policy 
on Humane Care and Use of Laboratory Animals.
A FPI was induced (~1.2 atm) in male C57/BL6 mice (~22–26 g) as previously described73. Sham mice received 
identical treatment as the FPI mice that included isoflurane anesthesia and craniotomy. As craniotomy alone 
induces low levels of inflammation, we use sham mice that receive the identical craniotomy procedure, but do not 
receive the FPI. All mice were group housed prior to procedures. Thereafter, mice were individually housed in a 
12:12 light dark cycle, with food and water available ad libitum. We had no mortality and all mice were included 
in the study. At 2 hrs (n = 3 sham & n = 3 FPI), 6 hrs (n = 11 sham & n = 11 FPI), 24 hrs (n = 12 sham & n = 12 
FPI), 3 days (n = 8 sham & n = 8 FPI), and 7 days (n = 6 sham & n = 6 FPI) after injury, mice were anesthetized 
with isoflurane, livers were rapidly dissected, and flash-frozen. In a separate group of mice used for immunohis-
tochemistry (N = 5 sham and n = 5 FPI), mice were perfused at 7 days post-FPI, as previously described73.
Real-time PCR. RNA was extracted from liver tissue (n = 3 sham & 3 FPI per time point) and real-time 
PCR was performed as previously described74 using commercially available primers against mouse ASBT, TGR5, 
OATP, NTCP, Shh, Ihh, Gli 1, Gli 2, Gli 3 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Qiagen, 
Frederick, MD). For these experiments, we used GAPDH as our loading control. It is pertinent to note that a 
two-tailed t test revealed a trend toward decreased GAPDH in the FPI group, compared to sham. Therefore, 
it is possible that the magnitude of change in hedgehog and Gli are underestimated, although the interpreta-
tions remain unchanged. The primers were purchased from commercially available source (SABiosciences; Cat. 
Number: PPR06557B). The RT-PCR inflammatory array has multiple housekeeping genes and in this experi-
ment heat shock protein 90 kDa Alpha Family Class B Member 1 (HSP90AB1) was found to be the most stable. 
Thus, the loading control used for analysis of this panel was HSP90AB1. In addition, we used an inflammatory 
cytokines and receptors RT2 profiler PCR Array system (Qiagen, Frederick, MD) following manufacturer’s pro-
tocols including analysis using their supplied software. For statistical analysis, the p values were calculated as 
previously described75 based on a Student’s t-test of the replicate 2^ (− Delta CT) values for each gene in the 
sham-treated groups and treatment groups with p values less than 0.05 considered significant. Data are expressed 
as mean relative mRNA levels + /− SEM.
Multiplex Assays for acute phase proteins and cytokines. Frozen liver tissue (n − 8 sham & 8 FPI 
at 6, 24 and 72 hrs post-FPI; n = 6 sham & n = 6 FPI at 7 days post-FPI) was homogenized in purification deter-
gent buffers of ProteoExtract® Cytoskeleton Enrichment and Isolation Kit (EMD Millipore, Billerica, MA) using 
MACS tissue homogenizer with protein setting. Then the sample is spun down at 1,000 G for 5 min and stored at 
− 20 °C. Multiplex assays were done as previously described in a previous study7 using the manufacturer’s protocol 
for both the cytokines (Millipore) acute phase protein analysis (Millipore). We used a custom acute phase panel 
containing CRP, haptoglobin and SAP (*currently available as part of kit: MAP2MAG-76K). For multiplexing, 
we used a custom cytokine panel consisting of CCL2, CCL5, CXCL1, IL-3 and IL-4. It should be noted that the 
IL-3 measurements were below the range of detection for the multiplex and no statistics were performed for this 
cytokine. For both sets of analysis, all assays were performed in triplicate and the averages of the 3 were used for 
statistical analysis. Statistical analysis was performed using one way ANOVA to compare sham vs. FPI at each 
time point.
Stereological analysis of immunocytochemical staining of ASBT-labeled hypothalamic neurons. 
Mice (n = 5 sham & n = 5 FPI) were perfused at 7 days after FPI, with saline followed by 4% paraformaldehyde and 
post-fixed, as previously described7. Serial sections were cut at 50 microns, using a vibratome sectioning system, 
as previously descried7. We selected every 6th section for stereological analysis of the hypothalamus. This brain 
region was selected because altered serum bile acids have been shown to influence the hypothalamic-pituitary 
axis40 and because the ASBT antibody selectively stains a population of hypothalamic neurons. ASBT antibody 
was generated (Pacific Immunology; Ramona, CA) as previously described76. Tissue was first rinsed 3 times for 
5 min each in phosphate-buffered saline (PBS), after which it was soaked in 0.5% solution of hydrogen peroxide 
(H2O2) in PBS for 30 min, then for 60 min in 1.0% H2O2 in PBS, followed by 30 min in 0.5%v H2O2 in PBS. After 
rinsing 3 times for 5 min each in PBS, the tissue was incubated free-floating, rotating for 24 hrs, in anti-ASBT 
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(1:200), with 0.001% triton-X, and normal goat serum (1:20) in PBS, at room temperature (RT). Tissue was then 
rinsed in PBS 3 times for 5 min each, after which is was incubated for 60 min by rotating at RT in biotinylated 
anti-rabbit IgG (1:200; Vector Labs, Burlingame, CA) in PBS with normal goat serum (1:20) and 0.001% triton-X. 
Tissue was rinsed in PBS 3 times for 5 min each, and then incubated in ABC kit as per manufacturer instructions 
(Vector Labs, Burlingame, CA) for 1 hr, rotating at RT. Tissue was rinsed in PBS and then reacted in the DAB kit, 
as per manufacturer instructions (Vector Labs, Burlingame, CA). A Student’s T test was used to compare sham 
and FPI groups.
Statistical analysis. Data are presented as means ± the standard error of the mean (SEM). Significant differ-
ences among groups were estimated as described and a value of P < 0.05 was considered statistically significant.
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